Literature DB >> 32408981

Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions: JACC State-of-the-Art Review.

Babar Hasan1, Georg Hansmann2, Werner Budts3, Alexandra Heath4, Zahra Hoodbhoy5, Zhi-Cheng Jing6, Martin Koestenberger7, Katharina Meinel7, Ana Olga Mocumbi8, Ganna D Radchenko9, Hannes Sallmon10, Karen Sliwa11, R Krishna Kumar12.   

Abstract

Challenges and special aspects related to the management and prognosis of pulmonary hypertension (PH) in middle- to low-income regions (MLIRs) range from late presentation to comorbidities, lack of resources and expertise, cost, and rare options of lung transplantation. Expert consensus recommendations addressing the specific challenges for prevention and therapy of PH in MLIRs with limited resources have been lacking. To date, 6 MLIR-PH registries containing mostly adult patients with PH exist. Importantly, the global prevalence of PH is much higher in MLIRs compared with high-income regions: group 2 PH (left heart disease), pulmonary arterial hypertension associated with unrepaired congenital heart disease, human immunodeficiency virus, or schistosomiasis are highly prevalent. This consensus statement provides selective, tailored modifications to the current PH guidelines to address the specific challenges faced in MLIRs, resulting in the first pragmatic and cost-effective consensus recommendations for PH care providers, patients, and their families.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  consensus statement; middle- and low-income countries; pulmonary hypertension

Mesh:

Year:  2020        PMID: 32408981     DOI: 10.1016/j.jacc.2020.03.047

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

1.  Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysis.

Authors:  Anand Reddy Maligireddy; Supriya Shore; A Sreenivas Kumar; S Harikrishnan; S Ajit Mullasari; B K Sastry; Sameer Gupta; Nikhil Choudhary; Auras R Atreya; Sonali Arora; Victor M Moles; Vallerie V Mclaughlin; Vikas Aggarwal
Journal:  Pulm Circ       Date:  2022-04-01       Impact factor: 2.886

Review 2.  Pulmonary hypertension in developing countries: Limiting factors in time to diagnosis, specialised medications and contextualised recommendations.

Authors:  G J Maarman
Journal:  Afr J Thorac Crit Care Med       Date:  2022-05-05

3.  Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study.

Authors:  Sophia Emmons-Bell; Catherine Johnson; Alexandra Boon-Dooley; Paul A Corris; Peter J Leary; Stuart Rich; Magdi Yacoub; Gregory A Roth
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

4.  An Exaggerated Rise in Pulmonary Artery Pressure in a High-Altitude Dweller during the Cold Season.

Authors:  Akylbek Sydykov; Abdirashit Maripov; Nadira Kushubakova; Kubatbek Muratali Uulu; Samatbek Satybaldyev; Cholpon Kulchoroeva; Djuro Kosanovic; Akpay Sarybaev
Journal:  Int J Environ Res Public Health       Date:  2021-04-10       Impact factor: 3.390

Review 5.  Pulmonary Hypertension in Pregnancy: Challenges and Solutions.

Authors:  Hesham Afify; Alexander Kong; Jopher Bernal; Islam Y Elgendy
Journal:  Integr Blood Press Control       Date:  2022-04-02

6.  Pulmonary Hypertension Registry of Kerala, India (PRO-KERALA): One-year outcomes.

Authors:  S Harikrishnan; Avinash Mani; Sanjay G; Ashishkumar M; Jaideep Menon; Rajesh G; R Krishna Kumar; A George Koshy; Thankachan V Attacheril; Raju George; Eapen Punnose; S M Ashraf; Arun Sr; Mohammed Cholakkal; Panniyammakal Jeemon; Stigi Joseph; Unni Govindan; Johny Joseph; Koshy Eapen; Madhu Sreedharan; Anil Kumar; K Venugopal
Journal:  Indian Heart J       Date:  2021-12-14

Review 7.  Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.

Authors:  Laurent Calvier; Joachim Herz; Georg Hansmann
Journal:  JACC Basic Transl Sci       Date:  2022-02-28

8.  Atrial Flow Regulator for Postcapillary Pulmonary Hypertension: First-in-Human Transcatheter AFR Device Implantations in RCM.

Authors:  Georg Hansmann; Anna Sabiniewicz; Robert Sabiniewicz
Journal:  JACC Case Rep       Date:  2022-05-31

9.  Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis.

Authors:  Hua-Xi Zou; Bai-Quan Qiu; Song-Qing Lai; Xue-Liang Zhou; Cheng-Wu Gong; Li-Jun Wang; Ming-Ming Yuan; An-Di He; Ji-Chun Liu; Huang Huang
Journal:  Biomed Res Int       Date:  2021-10-22       Impact factor: 3.411

Review 10.  Generating Evidence From Contextual Clinical Research in Low- to Middle Income Countries: A Roadmap Based on Theory of Change.

Authors:  Babar S Hasan; Muneera A Rasheed; Asra Wahid; Raman Krishna Kumar; Liesl Zuhlke
Journal:  Front Pediatr       Date:  2021-12-09       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.